Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous β-thalassemia
- 1 January 1994
- journal article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 55 (1) , 70-75
- https://doi.org/10.1038/clpt.1994.12
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: